Rockwell Medical IN (RMTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 28,316 | 25,832 | 22,676 | 22,093 | 23,771 |
| Cost of Goods | 22,077 | 21,282 | 19,612 | 19,223 | 21,569 |
| Gross Profit | 6,239 | 4,550 | 3,064 | 2,870 | 2,202 |
| Operating Expenses | 4,380 | 4,317 | 5,000 | 3,640 | 4,508 |
| Operating Income | 1,936 | 515 | -1,324 | -547 | -1,737 |
| Interest Expense | 302 | 232 | 431 | 1,108 | 411 |
| Other Income | 30 | 60 | 24 | 143 | 276 |
| Pre-tax Income | 1,664 | 343 | -1,731 | -1,512 | -1,872 |
| Net Income Continuous | 1,664 | 343 | -1,731 | -1,512 | -1,872 |
| Net Income | $1,664 | $343 | $-1,731 | $-1,512 | $-1,872 |
| EPS Basic Total Ops | 0.05 | 0.01 | -0.06 | -0.02 | -0.07 |
| EPS Basic Continuous Ops | 0.05 | 0.01 | -0.06 | -0.02 | -0.07 |
| EPS Diluted Total Ops | 0.04 | 0.01 | -0.06 | -0.02 | -0.07 |
| EPS Diluted Continuous Ops | 0.05 | 0.01 | -0.06 | -0.02 | -0.07 |
| EPS Diluted Before Non-Recurring Items | 0.05 | 0.01 | -0.02 | N/A | N/A |
| EBITDA(a) | $2,567 | $575 | $-41 | $1,315 | $448 |